[HTML][HTML] COVID-19: immunopathogenesis and Immunotherapeutics

L Yang, S Liu, J Liu, Z Zhang, X Wan… - … and targeted therapy, 2020 - nature.com
… are closely correlated with elevated cytokine levels, which could be utilized as a promising
therapeutic or prevention target for patients with COVID-19 and severe syndromes. …

Antithrombotic therapy in patients with COVID-19?-Rationale and Evidence

C Godino, A Scotti, N Maugeri, N Mancini… - International journal of …, 2021 - Elsevier
… A theoretical benefit could exist in terms of COVID-19 prevention, favouring mild or
asymptomatic manifestations of infectious disease, and in terms of treatment of patients with more …

Probiotics and prebiotics: potential prevention and therapeutic target for nutritional management of COVID-19?

KS Batista, JG de Albuquerque… - Nutrition research …, 2023 - cambridge.org
prevention/treatment methods and clinical outcomes of coronavirus disease 2019 (COVID-19
Nutritional status and diet have a major impact on the COVID-19 disease process, mainly …

[HTML][HTML] A short review on antibody therapy for COVID-19

GV Kumar, V Jeyanthi, S Ramakrishnan - New microbes and new infections, 2020 - Elsevier
… Those cross-neutralizing antibodies can target a common epitope on these viruses and
offers potential for the prevention and treatment of COVID-19. Monoclonal antibody therapy

COVID-19: General strategies for herbal therapies

S Soleymani, A Naghizadeh, M Karimi… - Journal of evidence …, 2022 - journals.sagepub.com
… the outbreak of a highly pathogenic human coronavirus. The world is facing a challenge …
on COVID-19. New drug discovery for the COVID-19 pandemic can encompass both prevention

Intramuscular AZD7442 (tixagevimab–cilgavimab) for prevention of Covid-19

MJ Levin, A Ustianowski, S De Wit… - … England Journal of …, 2022 - Mass Medical Soc
… severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) that have an extended
half-life and have been shown to have prophylactic and therapeutic effects in animal models. …

[HTML][HTML] Pharmaco-immunomodulatory therapy in COVID-19

JG Rizk, K Kalantar-Zadeh, MR Mehra, CJ Lavie… - Drugs, 2020 - Springer
… A randomized, double-blind, placebo-controlled, multicenter pivotal trial evaluating the role
of intravenous gimsilumab in the prevention and treatment of ARDS and mortality in COVID-…

[HTML][HTML] Updated diagnosis, treatment and prevention of COVID-19 in children: experts' consensus statement (condensed version of the second edition)

KL Shen, YH Yang, RM Jiang, TY Wang… - World Journal of …, 2020 - Springer
… and prevention of coronavirus disease 2019 (COVID-19) in … in the diagnosis and treatment
of COVID-19 in children, we … diagnosis, treatment and prevention of COVID-19 in children. …

Surfactant-based prophylaxis and therapy against COVID-19: A possibility

K Pramod, S Kotta, US Jijith, A Aravind, MA Tahir… - Medical …, 2020 - Elsevier
… We believe that surfactant therapy will prevent the attachment of the virus through its spike
glycoproteins. The surfactant present at the alveolar surface could interfere with the spike …

The Pathogenesis of Coronavirus Disease 2019 (COVID19): Evaluation and Prevention

H Ouassou, L Kharchoufa, M Bouhrim… - Journal of …, 2020 - Wiley Online Library
therapeutic drugs or vaccines for 2019 novel coronavirus … data related to Corona Virus
Disease 2019 (COVID-19) including … of COVID-19, with a special focus on infection control and …